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INTRODUCTION
Phyllodes tumor is a rare fibroepithelial tumor of the breast 
that accounts for less than 1% of all breast tumors [1]. Few cases 
have been published involving a synchronous invasive carcin- 
oma component within a phyllodes tumor [2-7]. This is the 
first documented case of a borderline malignant phyllodes   
tumor with both tubular carcinoma and lobular carcinoma in 
situ components within the same tumor mass.
CASE REPORT
A 53-year-old female presented with a several year history of 
a right painless breast mass in the right upper outer quadrant 
that had grown in size significantly during the last two years 
until referral for treatment. The patient had no increased risk 
factors and family history was negative for both breast and ovar-
ian cancers. The patient had been started on progesterone 10 
mg daily one year prior to presentation for oligomenorrhea. A 
core biopsy taken nine years prior to presentation was report-
ed as fibroadenoma. The patient was then followed biennially 
by the Ontario Breast Screening Program until the significant 
growth increase when a second core biopsy was recommended 
and was also consistent with fibroadenoma. Given the sudden 
increase in size, with the lesion now measuring 5.5×1.8 cm by 
mammogram (Figures 1, 2), the radiological/pathological cor-
relation rounds recommended a surgical assessment and exci-
sional biopsy for definitive diagnosis. An excisional biopsy was 
undertaken.
Grossly, the well-circumscribed pale-tan mass measured 6.5× 
3.6×2.4 cm, which in areas had a whorled appearance. Histol- 
ogically, focal areas of fibroadenomatous changes were noted 
(Figure 3A) while areas of leaf like architecture with variable 
cellularity of stromal component were present as well. Cytologic 
atypia was present throughout the stromal component ranging 
from minimal to moderate atypia and a variable number of 
mitoses were present (up to 7 to 8 per 10 high power fields), 
consistent with a diagnosis of phyllodes tumor with borderline 
malignant potential (Figure 3B). At the lateral portion of the 
excised mass there was a tubular carcinoma area with a greatest 
dimension of 2.4 cm (Figure 3C). The carcinoma cells were 
immunohistochemically positive for epithelial membrane an-
tigen, estrogen receptor, progesterone receptor and E-cadherin, 
but negative for S100 protein. Absence of basal myoepithelial 
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Phyllodes tumors are an infrequent breast tumor presentation. A 
phyllodes tumor with a synchronous invasive ductal carcinoma 
is rarely described and has never been reported with lobular car-
cinoma in situ component. A 53-year-old female presented with 
a nine-year history of twice core biopsy proven fibroadenoma. 
After an increase in the tumor’s growth velocity it was decided 
upon to undergo an excisional biopsy. Microscopic examination 
of the well-circumscribed pale-tan mass found focal areas of leaf 
like architecture with variable number of mitoses present, repre-
senting a phyllodes tumor of borderline malignant potential. Inci-
dentally, at one edge of the mass was found a tubular carcinoma 
and lobular carcinoma in situ components. Thorough, routine fol-
low-up of patients with biopsy proven benign breast masses is 
important to finding a masked malignant component.
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lining in tubules was confirmed by negativity for smooth mus-
cle myosin heavy chain and P63 (Figure 3D). Lobular carci-
noma in situ was also noted in this area and the diagnosis was 
confirmed by negativity of immunohistochemical stain for E-
cadherin (Figure 3E, 3F). Microcalcification was observed with-
in the tubular carcinoma. The surgical margins were not in-
volved by the tumor, but the tubular carcinoma was very close 
(0.1 mm) to the inked surface at the lateral and posterior edges.
Following the pathology review the patient had complete 
staging workup, including bone scan, liver ultrasound, and chest 
X-ray. These were all negative for metastases. A dedicated breast 
magnetic resonance image (MRI) was completed prior to re-
excision that demonstrated a few, scattered enhancing masses 
of unknown significance. Subsequently the patient underwent 
a re-excision for margin safety and sentinel lymph node biopsy. 
Pathology review of the re-excision found scerlosing adenosis 
and atypical ductal hyperplasia with no evidence of residual 
invasive or in situ carcinoma or phyllodes tumor components. 
The previously close margins of tubular carcinoma at the lateral 
and posterior aspect are now 4.0 cm and 2.8 cm from those 
margins, respectively. All three sentinel nodes were negative 
for malignancy.
This patient’s unique presentation was reviewed at breast 
tumor rounds at the Juravinski Cancer Centre with the deci-
sion for the patient to next be evaluated by the radiation oncol-
ogy team for adjuvant therapy.
DISCUSSION
Phyllodes tumors are rare breast fibroepithelial neoplasms 
that can be potentially aggressive. They are usually classified 
as benign, borderline, or malignant, depending upon stromal 
cellularity and overgrowth, cellular atypia, mitotic activity, and 
margin status. The local recurrence for these tumors range from 
4.3-36% with wide local excision (>1 cm margin), the standard 
primary treatment modality [8,9]. Additionally, distant metas-
tasis can occur in 10% of these patients. An invasive ductal car-
cinoma that is incidentally found within a borderline phyllodes 
tumor has been reported only once before in literature [10]. 
Our case showed a similar presentation to the previous one, 
and a lobular carcinoma in situ component was also accom- 
panied with the phyllodes tumor and invasive tubular carcinoma.
This patient was followed routinely for several years with a 
stable lesion, originally biopsied as fibroadenoma. During the 
interim the mass followed what is expected as a normal course 
for a fibroadenoma: overall stable size, sometimes minimal size 
alteration with menstrual cycles, painless, and well-circum-
scribed on radiographs. Given that both fibroadenomas and 
phyllodes tumors have similar clinical presentation of a pain-
less breast mass, physicians rely on accurate diagnostic imag-
ing, biopsy, and routine clinical follow-up for surveillance. A 
retrospective review of thirty-one histologically proven masses 
(19 fibroadenomas and 12 phyllodes tumors) examined the 
mammographic and sonographic differences between fibro-
epithelial lesions [11]. From that review the authors concluded 
there is substantial overlap in the radiographic characteristics 
of these tumors. They suggested that assured accurate diagno-
sis can only be made by core or excisional biopsy.
As a less invasive diagnostic modality to excisional biopsy, 
core biopsy of fibroepithelial lesions is a strong alternative for 
differentiating these tumors. In a study of sixty-seven Finnish 
females examining the efficacy of core biopsy of diagnosing 
between fibroadenoma and phyllodes tumor, they found a sen-
sitivity, specificity, and positive and negative predictive values 
of 83%, 92%, 71%, and 96%, respectively, for phyllodes tumors 
[12]. In this patient, even though the most recent repeat needle 
core biopsy confirmed again a fibroadenoma it was the signif-
Figure 1. Ultrasound (US) of right breast multilobulated, solid mass meas- 
ured 4.91×1.76 cm. Mildly heterogenous, paralleling the skin surface. 
In 2001 the tumor’s longest US dimension was 2.4 cm.
Figure 2. Mammography 
of right breast, craniocau-
dal view, showed a circum-
scribed, multilobulated solid 
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icant change in size of the tumor that raised concern of a more 
aggressive mass, leading to excision and incidentally finding 
the invasive carcinoma component. Unfortunately, review of 
this patient’s mammograms did not suggest an invasive carcin- 
oma component, given that it was within the well-circum-
scribed borderline phyllodes component.
Figure 3. (A) The mass revealed fibroadenomatous change (H&E stain, ×40). (B) Leaf-like structures of fibroepithelial lesion showed a cellular stroma 
with cytological atypia and increased mitosis (H&E stain, ×40). (C) Invasive carcinoma cells formed small tubules within the stroma (H&E stain, ×20). (D) 
Tubules of carcinoma cells were immunohistochemically negative for myoepithelial marker, p63 (IHC, ×40). (E) Lobular carcinoma in situ was noted within 
the glandular component (H&E stain, ×40). (F) Lobular carcinoma in situ was immunohistochemically negative for E-cadherin (×40). 
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In conclusion, a phyllodes tumor with a synchronous inva-
sive carcinoma component is rarely presented and routine fol-
low-up that involves clinical and radiologic assessment of fibro-
adenomas is important to curtail progression of a masked ma-
lignant component.240  SeanQuinlan-Davidson,etal.
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